Human defensin-1 (HNP-1) is a peptide possessing both broad antimicrobial (both Gram-positive and Gram-negative bacteria) and cytotoxic activities. HNP-1 reduces adenoviral infection by more than 95%.
CAT No: 10-101-279
CAS No:99287-08-8
Synonyms/Alias:Defensin HNP-1 human >=80% (HPLC);99287-08-8;136661-76-2(free acid basis);Defensin HNP-3 (human) trifluoroacetate salt;FD110457;FD110458;Defensin HNP-1 (human) trifluoroacetate salt;
Defensin HNP-1 (Human) is a naturally occurring antimicrobial peptide belonging to the alpha-defensin family, predominantly found in human neutrophils. Characterized by its distinct triple-stranded beta-sheet structure stabilized by disulfide bonds, this peptide exhibits remarkable stability and resistance to proteolytic degradation. Its amphipathic nature allows it to interact effectively with microbial membranes, leading to broad-spectrum antimicrobial activity. HNP-1 is a key component of the innate immune system, contributing to the first line of defense against a wide range of pathogens. Researchers value its ability to modulate immune responses, making it a significant molecule for studies in immunology, infectious disease, and host-pathogen interactions.
Antimicrobial Mechanism Research: Defensin HNP-1 (Human) is widely utilized in studies investigating the molecular mechanisms underlying innate immunity. By incorporating this peptide into in vitro assays, researchers can explore how it disrupts bacterial, fungal, and viral membranes, leading to cell lysis and pathogen clearance. Its unique interaction with lipid bilayers and ability to form pores provide valuable insight into the development of novel antimicrobial strategies and the design of synthetic analogs with enhanced efficacy.
Host-Pathogen Interaction Models: HNP-1 is frequently used in experimental models to examine the dynamics of host-pathogen interactions. By adding the peptide to cultures containing various microbial species and human cells, scientists can assess its impact on infection progression, immune signaling, and pathogen evasion tactics. These studies help elucidate the complex interplay between innate immune effectors and invading microorganisms, advancing our understanding of immune defense mechanisms.
Immunomodulation Studies: Human neutrophil peptide 1 has been shown to influence the activity of immune cells beyond its direct antimicrobial effects. It can modulate cytokine production, chemotaxis, and the activation of dendritic cells and T lymphocytes. By utilizing HNP-1 in cell-based assays, researchers can investigate its role in shaping immune responses, with implications for inflammatory disease models, vaccine adjuvant development, and immunotherapy research.
Biofilm Inhibition Assays: The capacity of defensins to prevent or disrupt biofilm formation is of significant interest in microbiology and biomaterials research. HNP-1 can be applied to in vitro biofilm models to evaluate its efficacy in inhibiting the establishment and persistence of microbial communities on surfaces. These findings are particularly relevant for the development of antimicrobial coatings, medical device sterilization protocols, and strategies to combat chronic infections associated with biofilms.
Antimicrobial Peptide Engineering: The structural and functional properties of HNP-1 serve as a template for the design and optimization of synthetic antimicrobial peptides. By studying its sequence motifs, charge distribution, and membrane-targeting mechanisms, researchers can engineer novel peptides with improved stability, selectivity, and antimicrobial potency. These engineered molecules have potential applications in research, biotechnology, and the development of next-generation antimicrobial agents.
Mucosal Immunity Investigations: In addition to its systemic immune functions, defensin HNP-1 (Human) is a valuable tool for exploring mucosal immunity. It can be introduced into ex vivo tissue models or organoid systems to assess its protective effects against pathogen invasion at epithelial barriers such as the respiratory, gastrointestinal, and urogenital tracts. These studies provide crucial insights into the maintenance of mucosal homeostasis and the prevention of infection at critical entry points. Through its diverse range of applications, Defensin HNP-1 (Human) continues to contribute to advances in immunology, microbiology, and peptide engineering, supporting innovative research across multiple scientific disciplines.
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More